Brian V Slater
Chair of Life Sciences at Haug Partners LLP
Brian V Slater is a partner in the New York office of Haug Partners LLP. Mr Slater is a first chair trial lawyer with over 25 years of experience litigating complex patent disputes. Mr Slater has led trial teams to success in a variety of forums, including federal district courts and the Patent Trial and Appeal Board, as well as in arbitration. Clients describe him as a “lead trial lawyer with a wealth of experience” and as a “great decision maker” who is “admired for his strategic nous and calm demeanour in pressurised litigation scenarios” (IAM Patent 1000).
Mr Slater has served as lead litigation counsel for life sciences innovators in high-value patent disputes, including Gilead, Merck and Sanofi. Among his notable successes, he led the team that helped Forward Pharma secure a $1.25 billion settlement in its worldwide patent dispute with Biogen over rights to its Tecfidera multiple sclerosis treatment.
Mr Slater has extensive experience in Hatch-Waxman patent litigation against ANDA (abbreviated new drug application) challengers and has been described by clients as “brilliant on biosimilars” (IAM Patent 1000 2014). His wide-ranging patent and trade secret litigation experience also includes cases involving biologics, medical devices, diagnostic kits, aircraft composites, toner cartridges, automotive parts, vending machines and magazine cover coatings.
Mr Slater previously served as chair of life sciences at Kramer Levin Naftalis & Frankel LLP. Before that, he spent over 20 years at Fitzpatrick, Cella, Harper & Scinto (now Venable LLP), where he served on the management committee and was chair of the due diligence practice.